News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,507 Results
Type
Article (86760)
Company Profile (704)
Press Release (764041)
Multimedia
Podcasts (140)
Webinars (18)
Section
Business (232778)
Career Advice (4130)
Deals (39749)
Drug Delivery (129)
Drug Development (91070)
Employer Resources (198)
FDA (18164)
Job Trends (17356)
News (396730)
Policy (39803)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (103)
Alliances (56951)
ALS (114)
Alzheimer's disease (1542)
Antibody-drug conjugate (ADC) (186)
Approvals (18114)
Artificial intelligence (378)
Autoimmune disease (35)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (125)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (38)
Breast cancer (378)
Cancer (2955)
Cardiovascular disease (237)
Career advice (3537)
Career pathing (34)
CAR-T (201)
CDC (38)
Cell therapy (553)
Cervical cancer (24)
Clinical research (74091)
Collaboration (1057)
Company closure (3)
Compensation (660)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (323)
Cystic fibrosis (117)
Data (2924)
Decentralized trials (2)
Denatured (49)
Depression (67)
Diabetes (368)
Diagnostics (6968)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (167)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (126)
Earnings (97428)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131320)
Executive appointments (895)
FDA (19799)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (969)
Gene editing (142)
Generative AI (37)
Gene therapy (420)
GLP-1 (915)
Government (5238)
Grass and pollen (6)
Guidances (180)
Healthcare (20914)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (172)
Immuno-oncology (8)
Indications (38)
Infectious disease (3075)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (66)
Intellectual property (119)
Interviews (813)
IPO (17892)
IRA (55)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (54)
Layoffs (582)
Leadership (25)
Legal (10130)
Liver cancer (84)
Lung cancer (419)
Lymphoma (206)
Machine learning (9)
Management (65)
Manufacturing (416)
MASH (92)
Medical device (14700)
Medtech (14705)
Mergers & acquisitions (22541)
Metabolic disorders (929)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2262)
NextGen: Class of 2025 (7687)
Non-profit (5089)
Now hiring (48)
Obesity (477)
Opinion (287)
Ovarian cancer (98)
Pain (115)
Pancreatic cancer (116)
Parkinson's disease (194)
Partnered (25)
Patents (301)
Patient recruitment (148)
Peanut (54)
People (65627)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22873)
Phase II (32169)
Phase III (24228)
Pipeline (1616)
Policy (229)
Postmarket research (3552)
Preclinical (10332)
Press Release (72)
Prostate cancer (142)
Psychedelics (40)
Radiopharmaceuticals (277)
Rare diseases (500)
Real estate (7399)
Recruiting (75)
Regulatory (27043)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (165)
Series B (108)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (63)
The Weekly (89)
Vaccines (884)
Venture capital (54)
Weight loss (325)
Women's health (48)
Worklife (20)
Date
Today (146)
Last 7 days (540)
Last 30 days (2549)
Last 365 days (34224)
2025 (17046)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (69)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50452)
Australia (8871)
California (7547)
Canada (2318)
China (695)
Colorado (324)
Connecticut (341)
Delaware (196)
Europe (115751)
Florida (1112)
Georgia (258)
Hawaii (1)
Idaho (65)
Illinois (720)
India (32)
Indiana (382)
Iowa (18)
Japan (223)
Kansas (115)
Kentucky (32)
Louisiana (17)
Maine (73)
Maryland (1080)
Massachusetts (5771)
Michigan (272)
Minnesota (470)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (73)
New Jersey (2110)
New Mexico (31)
New York (2121)
North Carolina (1219)
North Dakota (10)
Northern California (3250)
Ohio (244)
Oklahoma (16)
Oregon (48)
Pennsylvania (1619)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (35)
South Dakota (1)
Southern California (2777)
Tennessee (124)
Texas (1139)
United States (28532)
Utah (224)
Virginia (202)
Washington D.C. (80)
Washington State (666)
West Virginia (4)
Wisconsin (83)
There are 851,507 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abcentra Announces Appointment of Dr. Peter Libby as a Board Member as it Enters Orticumab’s Phase 2b Trial (FORTIFY)
June 24, 2025
·
3 min read
Press Releases
Bridge to Life Announces New FDA-Approved Indication for EasiSlush® Sodium Chloride Solution for Slush Preparation
June 24, 2025
·
2 min read
Press Releases
Longeveron® Announces Completion of Enrollment of Pivotal Phase 2b Clinical Trial Evaluating Laromestrocel as a Treatment for Hypoplastic Left Heart Syndrome (HLHS)
June 24, 2025
·
9 min read
Press Releases
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
June 24, 2025
·
9 min read
Press Releases
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention
June 24, 2025
·
4 min read
Press Releases
cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer
June 24, 2025
·
5 min read
Press Releases
Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa “Blue Zone”, Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World’s Longest-Lived Population
June 24, 2025
·
5 min read
Press Releases
PathPresenter Receives FDA 510(k) Clearance for Digital Pathology Clinical Viewer
June 24, 2025
·
2 min read
Press Releases
Zambon Announces Approval and Launch in China of the Intravenous Formulation of Fluimucil® (N-acetylcysteine)
June 24, 2025
·
3 min read
Press Releases
Avalo Therapeutics to Participate in Upcoming June 2025 Investor Conferences
June 24, 2025
·
1 min read
1 of 85,151
Next
